Clinigen
Mar 02, 2017
Clinigen and Eisai team up; Sanofi, Lonza enter; Fidia to acquire; J&J completes acquisition
Clinigen and Eisai partner to offer Halaven for metastatic breast cancer in South Africa Eisai has partnered with Clinigen Group to distribute Halaven (eribulin) in South Africa for the treatment of women with metastatic breast cancer. Discovered and developed by Eisai, Eribulin is a synthetic variant of microtubule...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
